Bristol-Myers, Merck Immune Therapy Promising in Cancer Trials
Alert: HALISTER Source: BN (Bloomberg News)
Tickers BMY US (Bristol-Myers Squibb Co) MRK US (Merck & Co Inc) 3400398Z US (HHS Food & Drug Administration)
People James Allison (Md Anderson Cancer Center) Joseph Hice (H Lee Moffitt Cancer Center) Nicholas Vogelzang (Comprehensive Cancer Centers of Nevada) Sarah Koenig (Bristol-Myers Squibb Co)
Topics Cancers Skin Cancer, Melanoma
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283